That headline is doing a lot of work before the science catches up
There are different drugs within the GLP-1 category, but semaglutide, which is a weekly injectable medication, is among the best known due to its large impact on weight and the fact that it was the first GLP-1 approved for weight loss
Recent studies suggest a potential association between semaglutide, a GLP-1 receptor agonist for type 2 diabetes and obesity, and an increased risk of NAION
*Upozornenie: inky produktu sa mu u jednotlivch osb li a mu sa li od inkov popsanch na webovch strnkach
Your personalized care plan with Weight Care+ also includes other aspects of weight loss treatment, such as nutrition and exercise support, so you can be sure they have your best interest in mind
and 2% internationally in 2025